XML 58 R23.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Recognized Stock-Based Compensation

The Company recognized stock-based compensation as follows:

 

 

 

Year Ended December 31,

 

 

 

2020

 

 

2019

 

 

2018

 

 

 

(In thousands)

 

Research and development

 

$

14,980

 

 

$

8,031

 

 

$

4,195

 

General and administrative

 

 

15,542

 

 

 

8,250

 

 

 

2,730

 

Total stock-based compensation

 

$

30,522

 

 

$

16,281

 

 

$

6,925

 

Summary of Share-based Payment Award, Stock Options, Valuation Assumptions

The estimated grant-date fair value of all the Company’s options to purchase common stock was calculated using the Black-Scholes option pricing model, based on the following assumptions:

 

 

 

Year Ended December 31,

 

 

 

2020

 

 

2019

 

 

2018

 

Expected term (in years)

 

5.3-6.1

 

 

5.3 – 6.1

 

 

5.1 – 6.1

 

Expected volatility

 

74%-78%

 

 

76% – 82%

 

 

73% – 81%

 

Risk-free interest rate

 

0.3% - 1.8%

 

 

1.4% – 2.6%

 

 

2.5% – 3.1%

 

Dividend yield

 

0%

 

 

0%

 

 

0%

 

Summary of Restricted Common Stock

Activity for the restricted common stock is shown below:

 

 

 

Number of

Shares

 

 

Weighted

Average

Grant

Date Fair

Value per

Share

 

Unvested restricted common stock as of

   December 31, 2018

 

 

1,917,848

 

 

$

6.95

 

Vested

 

 

(866,037

)

 

 

6.95

 

Forfeited

 

 

(56,973

)

 

 

6.95

 

Unvested restricted common stock as of

   December 31, 2019

 

 

994,838

 

 

 

6.95

 

Vested

 

 

(726,659

)

 

 

6.95

 

Forfeited

 

 

(81,754

)

 

 

6.95

 

Unvested restricted common stock as of

   December 31, 2020

 

 

186,425

 

 

 

6.95

 

Summary of Options to Purchase Common Stock

Activity for the options to purchase common stock shown below:

 

 

 

Number of

Options

 

 

Weighted

Average

Exercise

Price Per

Share

 

 

Weighted

Average

Remaining

Contractual

Term

 

 

Aggregate

Intrinsic

Value

 

 

 

 

 

 

 

 

 

 

 

(In years)

 

 

(In thousands)

 

Outstanding as of December 31, 2018

 

 

5,063,688

 

 

$

8.94

 

 

 

 

 

 

 

 

 

Granted

 

 

3,738,071

 

 

 

17.74

 

 

 

 

 

 

 

 

 

Exercised

 

 

(180,287

)

 

 

8.43

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(178,648

)

 

 

11.52

 

 

 

 

 

 

 

 

 

Outstanding as of December 31, 2019

 

 

8,442,824

 

 

 

12.79

 

 

 

 

 

 

 

 

 

Granted

 

 

5,597,148

 

 

 

15.35

 

 

 

 

 

 

 

 

 

Exercised

 

 

(655,772

)

 

 

9.65

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(729,202

)

 

 

14.96

 

 

 

 

 

 

 

 

 

Outstanding as of December 31, 2020

 

 

12,654,998

 

 

$

13.96

 

 

 

8.7

 

 

$

39,633

 

Exercisable as of December 31, 2020

 

 

3,588,568

 

 

$

12.74

 

 

 

8.1

 

 

$

13,393

 

Vested and expected to vest as of December 31,

   2020

 

 

12,654,998

 

 

$

13.96

 

 

 

8.7

 

 

$

39,633